Pharmala Biotech Holdings Inc.
MDMA
CNSX
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -13.47% | 638.32% | -54.41% | -14.47% | 1,123.57% |
| Total Receivables | -14.99% | -19.06% | -11.56% | -30.68% | -22.37% |
| Inventory | 16.61% | -5.51% | -3.70% | 76.43% | 1,880.00% |
| Prepaid Expenses | 10.41% | 118.45% | -46.80% | 76.61% | -85.74% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -7.79% | 160.41% | -28.10% | 1.38% | 51.87% |
|
|
|||||
| Total Current Assets | -7.79% | 160.41% | -28.10% | 1.38% | 51.87% |
| Net Property, Plant & Equipment | -- | -- | -- | -50.00% | -33.33% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 3.66% | -4.64% | -3.93% | 2.44% | 1.25% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -2.47% | 44.26% | -12.65% | 2.04% | 15.14% |
|
|
|||||
| Total Accounts Payable | 26.70% | 36.35% | -51.86% | 1.66% | -23.20% |
| Total Accrued Expenses | -- | -64.20% | -23.81% | 57.14% | -71.40% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 4.21% | -3.37% | 15.93% | 6.73% | -13.57% |
| Total Other Current Liabilities | 4.21% | -3.37% | 15.93% | 6.73% | -13.57% |
| Total Current Liabilities | 13.17% | 8.77% | -23.84% | 4.91% | -22.78% |
|
|
|||||
| Total Current Liabilities | 13.17% | 8.77% | -23.84% | 4.91% | -22.78% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 13.17% | 8.77% | -23.84% | 4.91% | -22.78% |
|
|
|||||
| Common Stock & APIC | 7.31% | 13.17% | 2.22% | 2.71% | 13.41% |
| Retained Earnings | -13.72% | -11.56% | -5.63% | -5.90% | -8.99% |
| Treasury Stock & Other | 4.90% | 213.29% | -3.69% | 44.84% | -- |
| Total Common Equity | -6.57% | 57.78% | -7.46% | 0.77% | 47.27% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -6.57% | 57.78% | -7.46% | 0.77% | 47.27% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -6.57% | 57.78% | -7.46% | 0.77% | 47.27% |
|
|
|||||